Holen Sie sich die Stockscreener-App
29.51
1.24%
-0.37
Handel nachbörslich:
29.51
Finanzdaten der Celldex Therapeutics Inc-Aktie (CLDX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.121
|
- | 0.73 | 0.695 | 1.175 |
Operating Expenses
|
18.28%
87.07
|
73.62 | 64.59 | 63.43 | 57.00 |
| Benefits Costs and Expenses |
20.31%
58.66
|
73.62 | 64.59 | 63.43 | 19.99 |
| Costs And Expenses |
18.55%
87.27
|
73.62 | 64.59 | 63.43 | 57.20 |
| Operating Income/Loss |
18.39%
-87.15
|
-73.62 | -63.86 | -62.74 | -56.03 |
| Income/Loss From Continuing Operations Before Tax |
20.48%
-58.54
|
-73.62 | -56.60 | -53.80 | -18.81 |
| Income/Loss From Continuing Operations After Tax |
21.29%
-81.32
|
-67.04 | -56.60 | -53.80 | -7.271 |
|
Net Income/Loss
|
21.29%
-81.32
|
-67.04 | -56.60 | -53.80 | -47.09 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99,803%
66.36
|
0.0664 | 0.0664 | 0.0664 | 0.000658 |
| Diluted Average Shares |
99,803%
66.36
|
0.0664 | 0.0664 | 0.0664 | 0.000658 |
| Basic Earnings Per Share |
21.78%
-1.23
|
-1.01 | -0.85 | -0.81 | -0.71 |
| Diluted Earnings Per Share |
21.78%
-1.23
|
-1.01 | -0.85 | -0.81 | -0.71 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):